2015-2019 Italy Cancer Diagnostics Industry: Market Segmentation Analysis - Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains - Hospitals, Commercial Labs

August 2015 | 570 pages | ID: 26265B069F1EN
Venture Planning Group

Abstracts

Complete report $6,700. DataPack (test volumes, sales forecasts, supplier shares) $4,350. The report is available by section, market segment, and can be custom-tailored to your specific information needs and budget.

2015-2019 Market Segmentation Analysis of the Italian Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Hospitals and Commercial Labs is VPGMarketResearch's new study of the major business opportunities emerging in the Italian cancer diagnostics market during the nextfive years. The report examines trends in the Italian market; reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the Italian cancer diagnostics market is promising to be an exciting, dynamic and rapidly expand ing field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Italian Market Overview

• Five-year test volume and sales projections.
• Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers.
• Estimated universe of laboratories performing cancer diagnostic testing.
• Cancer statistics, etiology and recent developments in Italy.

Business Opportunities and Strategic Recommendations

• Specific new product development opportunities with potentially significant market appeal during the next five years.
• Design criteria for new products.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Over 200 Current and Emerging Cancer Diagnostic Test

• Oncogenes
• Biochemical Markers
• Growth Factors
• Colony Stimulating Factors
• Hormones
• Immunohistochemical Stains
• Lymphokines

Supplier Shares, Sales and Volume Forecasts

• Sales and market shares of major cancer diagnostic product suppliers by individual test.
• Five-year test volume and sales forecasts for major tumor markers by market segment, including:
• Hospitals
• Commercial/Private Laboratories

Instrumentation Review

• Analysis of major molecular diagnostic and immunodiagnostic analyzers used for cancer testing, including their operating characteristics, features and selling prices.

Technology Assessment

• Assessment of latest technologies and their potential applications for cancer diagnostic testing.
• Review of competing/complementing technologies.
• Extensive listings of companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Strategies

Strategic assessments ofmajor suppliers and start-up firms developing innovative cancer diagnostic technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

The companies analyzed in the report include:

• Abbott
• AdnaGen
• Agilent Technologies
• Applied Gene Technologies
• Arca Biopharma
• Beckman Coulter/Danaher
• Becton Dickinson
• Biomedical Diagnostics
• bioMerieux
• Bio-Rad
• CellSearch
• Cepheid
• Correlogic Systems/Vermillion
• Decode Genetics
• Diadexus
• Diagnocure
• DiaSorin
• Eiken Chemical
• Elitech Group
• Epigenomics
• Enterix
• Enzo Biochem
• Exact Sciences
• Fujirebio
• Guided Therapeutics
• Hologic/Gen-Probe
• Kreatech/Leica
• Kyowa Medex
• Mackay Life Sciences
• Myriad Genetics
• OncoLab
• Ortho-Clinical Diagnostics
• Panacea Pharmaceuticals
• Polartechnics
• Polymedco
• PreMD
• Qiagen
• Quest Diagnostics
• Radient Pharmaceuticals
• Roche
• Scienion
• Sequenom
• Siemens Healthcare
• Takara Bio
• Targeted Diagnostics & Therapeutics
• Thermo Fisher
• Tosoh
• Veridex
• Wako Pure Chemicals
• Wallac/PE
• Zilla

Contains 570 pages and 83 tables

Contents

1. Introduction

2. Worldwide Market Overview

A. Market Overview
B. Worldwide Market Structure
C. Worldwide Market Size and Growth

3. Major Product Development Opportunities

A. Reagent Kits and Test Systems/Panels
B. Instrumentation
C. Computers, Software and Automation
D. Auxiliary Products

4. DESIGN CRITERIA FOR DECENTRALIZED TESTING PRODUCTS

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

7. Worldwide Market and Technology Overview

A. Major Current and Emerging Cancer Diagnostic Tests
  1. BIOCHEMICAL TUMOR MARKERS
  2. ONCOGENES
  3. POLYPEPTIDE GROWTH FACTORS
  4. ECTOPIC HORMONES
  5. COLONY STIMULATING FACTORS
  6. LYMPHOKINES
  7. IMMUNOHISTOCHEMICAL STAINS
  8. EMERGING TUMOR MARKERS
B. Instrumentation Review and Market Needs
C. CURRENT AND EMERGING TECHNOLOGIES
D. Personal Testing

8. Italy


A. EXECUTIVE SUMMARY
B. Business Environment
C. Market Structure
D. Market Dynamics, Trends, Size and Growth
  Volume Forecasts by Test and Market Segment
  Sales Forecasts by Test and Market Segment
  Major Supplier Sales and Market Shares

9. Competitive Profiles


  Abbott
  AdnaGen
  Agilent Technologies
  Applied Gene Technologies
  Arca Biopharma
  Beckman Coulter/Danaher
  Becton Dickinson
  Biomedical Diagnostics
  bioMerieux
  Bio-Rad
  CellSearch
  Cepheid
  Correlogic Systems/Vermillion
  Decode Genetics
  Diadexus
  Diagnocure
  Diasorin
  Eiken Chemical
  Elitech Group
  Epigenomics
  Enterix
  Enzo Biochem
  Exact Sciences
  Fujirebio
  Guided Therapeutics
  Hologic/Gen-Probe
  Kreatech/Leica
  Kyowa Medex
  Mackay Life Sciences
  Myriad Genetics
  OncoLab
  Ortho-Clinical Diagnostics
  Panacea Pharmaceuticals
  Polartechnics
  Polymedco
  PreMD
  Qiagen/Ipsogen
  Quest Diagnostics
  Radient Pharmaceuticals
  Roche
  Scienion
  Sequenom
  Siemens Healthcare
  Takara Bio
  Targeted Diagnostics & Therapeutics
  Thermo Fisher
  Tosoh
  Veridex
  Wako Pure Chemicals
  Wallac/PE
  Zila

10. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List Of Tables

LIST OF TABLES

Cancer Diagnostic Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta-2 Microglobulin Tests
Major Companies Developing or Marketing CA 15-3/27.29 Tests
Major Companies Developing or Marketing CA 19-9 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis
EXECUTIVE SUMMARY Table: Italy, Total Cancer Diagnostic Testing Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estimated Cancer Death Rates
Italy, Laboratories Performing Cancer Diagnostic Tests by Market Segment
Italy, Hospital Laboratories Performing Cancer Diagnostic Tests by Bed Size
Italy, Commercial/Private Laboratories Performing Cancer Diagnostics Tests By Annual Test Volume
Italy, Total Cancer Diagnostic Test Volume Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Test Volume Forecasts
Italy, Total Cancer Diagnostic Test Market Forecasts by Market Segment
Italy, All Market Segments Major Cancer Diagnostic Sales Forecasts by Test
Italy, Hospital Laboratories Major Cancer Diagnostic Forecasts by Test
Italy, Commercial/Private Laboratories Major Cancer Diagnostic Sales Forecasts by Test
Italy, ACTH Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, AFP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA-19-9 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CA 125 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Calcitonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, CEA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Chromogranin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Colon Specific Antigen Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Cytokeratins Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecasts by MarketSegment
Italy, Ferritin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Gastrin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, HCG Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Insulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, NSE Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Occult Blood Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Oncogenes Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, PAP Smear Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecasts by MarketSegment
Italy, PAP Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, PSA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, S-100 Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Serotonin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Sialic Acid Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecasts By Market Segment
Italy, TDT Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, TPA Test Volume and Diagnostics Sales Forecasts by Market Segment
Italy, Total Cancer Diagnostics Sales by Major Suppliers
Italy, AFP Testing Market Diagnostics Sales by Major Supplier
Italy, CEA Testing Market Diagnostics Sales by Major Supplier
Italy, PSA Testing Market Diagnostics Sales by Major Supplier